Yes, private label bifida ferment lysate serums can be sold in the EU and UK, but the compliance requirements are materially more demanding than for US-only distribution, and they must be satisfied before the first unit is placed on the market—not retroactively.
For the EU, the governing regulation is EU Cosmetics Regulation No. 1223/2009. The key requirements are: (1) A Responsible Person (RP) established within the EU who takes legal responsibility for compliance. If you are a non-EU brand, you must appoint an EU-based RP—typically a regulatory affairs firm or a European distributor that accepts RP status. RP services typically cost €300–€900 per product per year. (2) A Product Information File (PIF) maintained by the RP, containing the product description, CPSR, manufacturing method, efficacy substantiation, and safety data for all ingredients. (3) A Cosmetic Product Safety Report (CPSR) signed by a qualified toxicologist (holding a degree in pharmacy, toxicology, medicine, or a related discipline per Annex I of the regulation). CPSR preparation costs €500–€2,000 per product depending on formula complexity. Bifida ferment lysate is not a restricted or banned substance under EU Annex II, III, or V, so there are no specific EU restrictions on its use in serums. (4) CPNP notification via the EU's Cosmetic Products Notification Portal before placing the product on the EU market. This is done by the RP and is free of charge but requires the full PIF to be complete. (5) Labeling must include the RP's name and EU address, country of origin if manufactured outside the EU, the period after opening (PAO) symbol, a full INCI list, any required precautionary statements, and a batch number traceable to manufacturing records.
For the UK post-Brexit, Great Britain (England, Scotland, Wales) operates under the UK Cosmetics Regulation (retained EU law as amended), which mirrors the EU regulation structurally but requires a UK Responsible Person, a UK CPNP-equivalent notification via the Office for Product Safety and Standards (OPSS) Submit Cosmetic Product Notifications service, and UK-address labeling. Northern Ireland continues under EU rules for cosmetics sold in NI. If you are selling in both EU and GB, you need two separate Responsible Person arrangements and two separate notifications.
On ingredient restrictions: bifida ferment lysate is permitted in both EU and UK cosmetics without concentration limits. However, if your serum also contains fragrance allergens, preservatives listed in Annex V, or UV filters, those are subject to specific EU/UK concentration limits and labeling requirements that must be reflected in the CPSR.
The most common mistake for indie founders entering the EU market is assuming their US-compliant safety documentation transfers directly. It does not—a US safety assessment is not equivalent to an EU CPSR signed by a qualified toxicologist, and an FDA cosmetic product listing is not a substitute for CPNP notification. Budget 8–14 weeks for EU regulatory preparation running in parallel with your manufacturing timeline, and engage your Responsible Person at the same time you engage your contract manufacturer. AJ Cosmo Labs can connect you with regulatory consultants who specialize in EU and UK cosmetics compliance alongside your manufacturing search.
Read the full guide on Private Label Bifida Ferment Lysate Serum Manufacturer Low MOQ →